TABLE 2.
Neurochemical and hormonal regulation of ejaculation.
Neurotransmitter/hormone | Effect |
---|---|
Dopamine | Stimulates ejaculation through D2-like receptors (D2, D3, and D4 receptors, mainly D3) |
Serotonin | Inhibits ejaculation in the brain and stimulates it in the spine through the receptors 5HT, with 1A, 1B, and 2C |
Nitric oxide | Inhibits ejaculation through reduction of seminal vesicle contraction and seminal emission |
Oxytocin | Synthesized in the supraoptic and PVN of the hypothalamus and released from the posterior pituitary gland |
Augments powerful epididymal contractions and sperm motility | |
Acts in the CNS to stimulate ejaculation | |
Prolactin | Secreted from the pituitary gland |
Hyperprolactinemia has a marked inhibitory effect on male sexual desire, through inhibition of GnRH (therefore T production) and dopamine production | |
Thyroid hormones | Hypothyroidism and hyperthyroidism are associated with delayed and premature ejaculation, respectively |
Glucocorticoids | Cortisol levels are elevated after ejaculation in animal studies |
No change in cortisol levels in humans | |
Replacement of cortisol in Addison disease improves sexual function including orgasm | |
Estrogens | Regulates the emission phase of ejaculation through the regulation of epididymal contractility, luminal fluid reabsorption, and sperm concentration |
Androgens | Low levels are associated with delayed ejaculation, whereas high levels are associated with premature ejaculation |
Facilitates the control of the ejaculatory reflex through its androgen receptors in the MPOA and other areas in the CNS | |
Pelvic floor muscles involved in ejaculation are androgen dependent |
Note: CNS = central nervous system; MPOA = medial preoptic area; PVN = paraventricular nucleus.